| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 18.873 | 17.344 | 17.075 | 16.762 | 16.437 | 9.923 | - | - | - | - |
| Total Income - EUR | 18.873 | 17.344 | 17.075 | 16.762 | 16.437 | 9.923 | - | - | - | - |
| Total Expenses - EUR | 11.635 | 10.735 | 13.578 | 12.925 | 13.466 | 8.125 | - | - | - | - |
| Gross Profit/Loss - EUR | 7.238 | 6.609 | 3.497 | 3.836 | 2.971 | 1.799 | - | - | - | - |
| Net Profit/Loss - EUR | 6.672 | 6.089 | 2.985 | 3.334 | 2.478 | 1.524 | - | - | - | - |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - |
Check the financial reports for the company - Silmed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - |
| Current Assets | 46.916 | 13.101 | 15.713 | 14.514 | 11.390 | 12.622 | - | - | - | - |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - |
| Receivables | 45.872 | 11.937 | 13.705 | 13.432 | 10.821 | 12.269 | - | - | - | - |
| Cash | 1.044 | 1.164 | 2.007 | 1.082 | 569 | 352 | - | - | - | - |
| Shareholders Funds | 46.774 | 12.750 | 15.519 | 14.270 | 11.203 | 12.515 | - | - | - | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | - | - | - | - |
| Debts | 142 | 351 | 194 | 244 | 186 | 106 | - | - | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Silmed S.r.l.